Sun Pharma Advanced Research Shares Tank 20% after Psoriasis medicine failed with trials of 2
Parts of Sun Pharma Advanced Research Company (sparc), a unit of largest medicine maker in India Sun Pharmaceutical IndustriesTumbled as much as 20% on wednesday to RS 156.50 on the bse after the company disclosed that its investigational drug scd-044 failed to meet the main goals in late-stage clinical trials for psoriasis and atopic dermatitis….